In the specialized field of peptide research and biochemical analysis, identifying compounds that can selectively modify cellular environments without inducing the typ Polymyxin B Nonapeptide | C43H74N14O11 - PubChem - NIH ical toxicity associated with parent molecules is a primary objective. One such compound that has garnered significant attention in laboratory settings is polymyxin B nonapeptide (PMBN). My experience with this peptide has highlighted its unique utility as an experimental tool for membrane studies.
Chemical Profile and Structural Significance
Polymyxin B nonapeptide (PMBN) is a cyclic peptide derivative obtained from the natural polymyxin B (PmB) molecule through the proteolytic removal of the terminal amino acyl residue. With a molecular formula of C43H74 The effect of polymyxin B nonapeptide (PMBN) on N14O11 and a CAS number of 86408-36-8, this molecule is distinct in its biochemical behavior. Unlike the parent compound, which acts as a potent antimicrobial agent through membrane disruption, PMBN is characterized as a nonlethal PmB nonapeptide (PmBN) in many experimental models.
The primary structural advantage of PMBN is its ability to serve as an antibiotic potentiator. Because it lacks the side-chain terminal fatty acyl diaminobutyrate, it effectively loses the traditional bactericidal a Polymyxin B nonapeptide | A cationic cyclic peptide ctivity associated with the polymyxin family. However, it retains a high affinity for lipopolysaccharides (LPS), allowing it to bind specifically to the outer membrane (OM) of Gram-negative bacteria.
Mechanisms of Membrane Interaction
The research utility of PMBN lies in its ability to increase the permeability of the outer membrane (OM) of GNB (Gram-negative bacteria). By disrupting the integrity of the outer membrane, it facilitates th Polymyxin Derivative - an overview e diffusion of various molecules into the periplasm that would otherwise be excluded.
- Selective Permeabilization: PMBN disrupts Gram-negative bacteria membranes by binding to the lipid A portion of LPS.
The structure of PMBN is highly specific for efficient perturbation of the outer membrane of Gram-negative bacteria as well as for LPS binding.- Synergistic Potential: My observation of experimental data consistently shows that a double combination of AZM and Polymyxin B nonapeptide (PMBN) can significantly alter susceptibility profiles in laboratory assays.
- LPS Binding: Its capacity to interact with the outer membrane is highly specific, which is why it is frequently utilized in studies exploring the permeability barriers of bacterial cells.
Safety and Toxicity Profile
When comparing polymyxin B nonapeptide (PMBN) to the parent molecule, the safety profile is a major point of interest. It is well-documented that PMBN is less toxic than polymyxin B. Specifically, while polymyxin B is known for potential nephrotoxicity and neurotoxicity, PMBN was >50-fold less cytotoxic than polymyxin B toward various cell lines in vitro. This reduced toxicity makes it a valuable asset for researchers who need to modulate membra by F Al-Marzooq · 2022 · Cited by 21 — In this study, we investigated the synergistic effect of a polymyxin derivative known as polymyxin B nonapeptide (PMBN) with azithromycin (AZT). ne permeability without the confounding variables of high cellular toxicity.
Practical Applications in Research
In my laboratory work, the use of polymyxin B nonapeptide is primarily focused on its role as a sensitizing agent. Because Polymyxins are antibiotics that are generally effective against Gram-negative infections, using a derivative like PMBN allows for the study of resistance mechanisms.
1. Permeability Studies: It is frequently used to investigate the outer membrane barrier function.
2. Combination Assays: Researchers often pair PMBN with other molecules to test if the loca Polymyxin lized membrane disruption allows for increased intracellular accumulation of test compounds.
3. Persister Cell Eradication: Recent studies have suggested that PMBN can enhance the eradication of persister cells, providing a mechanism to study how membrane integrity affects bacterial survival under stress.
Conclusion
The development of polymyxin B nonapeptide (PMBN) represents a significant milestone in peptide chemistry. By decoupling the permeabilizing effects of the polymyxin scaffold from its lethal bactericidal activity, scientists have gained a precise tool for investigating membrane dynamics. Whether it is used as a The structure of PMBN is highly specific for efficient perturbation of the outer membrane of Gram-negative bacteria as well as for LPS binding. standalone probe or as an antibiotic potentiator in synergistic studies, PMBN remains a cornerstone for those studying the complexities of the Gram-negative cell envelope. Its structural specificity, combined with its favorable safety profile compared to polymyxin B, ensures its continued importance in analytical and biochemical research.